Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial
The company said more than 90% of patients started atirmociclib within three months of stopping their previous cancer medicine Source: ...
The company said more than 90% of patients started atirmociclib within three months of stopping their previous cancer medicine Source: ...
The company studied the pill in HIV patients whose virus was already suppressed, including those switching from complex multi-tablet regimens ...
Scientists say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an ...
A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.